Add BrightSurf on Google Email

American Thoracic Society


Promising drug fails to improve COPD symptoms

A promising anti-inflammatory drug failed to improve symptoms of moderate to severe chronic obstructive pulmonary disease (COPD) in a large trial. The study suggests that other mediators may be necessary to cause COPD, and raises concerns about the safety of the drug.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 1, 2007

High-dose inhaled corticosteroid use for COPD could cut risk of lung cancer

Researchers found that regular high-dose inhaled corticosteroid use among COPD patients lowered the risk of developing lung cancer. The study, published in the American Journal of Respiratory and Critical Care Medicine, found a significant reduction in relative risk for users of over 1,200 micrograms per day.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateApr 2, 2007

Obstructive sleep apnea patients show silent brain infarction lesions

Research suggests that obstructive sleep apnea patients with moderate to severe disease are at higher risk for stroke due to silent brain infarction lesions. The use of continuous positive airway pressure therapy has been shown to lower markers of platelet activation and reduce the incidence of subsequent ischemic brain lesions.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 15, 2007

A higher physical activity level slows lung function decline in smokers

A large retrospective cohort study found that moderate to high levels of regular physical activity slow lung function decline among smokers and reduce the risk of developing chronic obstructive pulmonary disease (COPD). Regular exercise suppresses inflammatory markers in the lungs caused by smoking, reducing COPD pathogenesis.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 1, 2007

Low-dose aspirin offers lower chance of asthma

A large randomized controlled trial found that taking low-dose aspirin every other day can reduce the risk of newly diagnosed adult-onset asthma by 22 percent. The study, published in the American Journal of Respiratory and Critical Care Medicine, involved over 22,000 healthy male physicians aged 40 to 84 years.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJan 15, 2007

Combination therapy reduces exacerbations in severe COPD

A study published in the American Journal of Respiratory and Critical Care Medicine found that combining a long-acting bronchodilator with an inhaled corticosteroid reduced exacerbations by 35% in patients with severe chronic obstructive pulmonary disease (COPD). The treatment was well-tolerated, but raised concerns about potential sys...

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJan 15, 2007

Change in guidelines could help eliminate TB in US

Current guidelines only target US-born residents for TB testing; new changes aim to address the burden of latent TB infection in foreign-born populations, particularly those from high-risk countries. Eliminating TB will require a comprehensive strategy involving varying approaches for immigrant populations.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJan 2, 2007

Fluid displacement from legs to neck can lead to obstructive sleep apnea

Research found that fluid displacement from the legs to the neck can narrow soft tissue around the throat and increase airflow resistance in healthy individuals, predisposing them to obstructive sleep apnea. The study involved measuring leg fluid volume, neck circumference, and airflow resistance in 11 non-obese subjects, with results ...

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateDec 15, 2006

Exposure to environmental tobacco smoke causes respiratory symptoms in healthy adults

Exposure to environmental tobacco smoke (ETS) was strongly associated with the development of respiratory symptoms, including cough, wheeze, and dyspnea, in healthy never-smokers. The study found a particular risk among individuals with bronchial hyper-reactivity who were persistently exposed to ETS.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateNov 15, 2006

American Thoracic Society publishes new statement on hepatotoxicity of antituberculosis therapy

The American Thoracic Society has published a new statement on the pathogenesis, prevention and treatment of liver damage caused by anti-tuberculosis medications. The document provides recommendations for identifying risk factors, recognizing symptoms and developing safe treatment programs.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateNov 7, 2006

A simple, noninvasive test measures survival time in adult pulmonary hypertension

Researchers developed a simple, noninvasive test to measure right ventricular function and predict survival of adults with pulmonary hypertension. The test, TAPSE, assesses echocardiographic abnormalities in the tricuspid valve and showed that patients with advanced right ventricular dysfunction had dramatically reduced survival rates.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateNov 1, 2006

Upgrading donor lung quality to improve availability

Researchers enhanced donor lungs using clinical maneuvers, increasing transplant procedures without compromising recipient function. The San Antonio Lung Transplant protocol improved lung procurement rates by up to 50%, reducing lengthy wait times and potentially eliminating deaths among patients awaiting lung transplantation.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateSep 15, 2006

Study reveals sleepiness and performance impairment in commercial drivers

A study of 340 drivers found that chronic short sleep duration and severe sleep apnea increase the risk of sleepiness, performance impairment, and decreased task vigilance while driving. The researchers suggest that the Federal Motor Carrier Safety Administration should implement plans to identify and treat sleep-impaired drivers.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 15, 2006

World Trade Center dust cuts lung function capability in rescue workers

A large-scale study found that NYC firefighters' lung function declined by 12 years of age due to WTC dust exposure, with early arrival time-based periods showing more frequent respiratory symptoms. Researchers emphasize the importance of medical surveillance for high-risk jobs and call for better protective equipment.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 1, 2006

TB relapse due to low weight gain after initial treatment

A study found that TB patients underweight at diagnosis who gain less than 5% weight during the first two months of treatment have a significantly increased risk of disease relapse. This association holds even among those with abnormal chest x-rays and positive sputum cultures after 2 months of anti-tuberculosis treatment.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 1, 2006

Biomarker reduces length of antibiotic treatment

A biomarker named procalcitonin can reduce the length of antibiotic treatment for community-acquired pneumonia (CAP) patients. Studies found that lower procalcitonin levels could shorten antibiotic use by an average of seven days, but guidelines suggest shorter courses and caution against over-reliance on this marker.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 30, 2006

Risk of ventilator-associated pneumonia cut significantly

Researchers found that treating intubated patients with chlorhexidine paste reduced the risk of ventilator-associated pneumonia by 65%, while a combination of chlorhexidine and colistin cut the risk by 55%. The study, published in the American Journal of Respiratory and Critical Care Medicine, suggests a cost-effective approach to prev...

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 15, 2006

Stopping inhaled corticosteroid use causes no problems in cystic fibrosis patient users

Researchers found that stopping inhaled corticosteroids in cystic fibrosis patients had no significant increase in lung-related adverse effects. The study showed that replacing the medication with a placebo was safe for most patients, suggesting that it may be possible to lower drug burden and reduce side effects.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 15, 2006